Newtyn Management, LLC Atai Life Sciences N.V. Transaction History

Newtyn Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.17 - $2.7 $421,200 - $972,000	360,000 Added 60.0%	960,000 $1.74 Million
Q4 2022 Feb 14, 2023	BUY	$2.38 - $3.55 $309,400 - $461,500	130,000 Added 27.66%	600,000 $1.6 Million
Q2 2022 Aug 15, 2022	BUY	$3.03 - $5.32 $666,187 - $1.17 Million	219,864 Added 87.9%	470,000 $1.71 Million
Q1 2022 May 16, 2022	BUY	$4.66 - $7.66 $23,300 - $38,300	5,000 Added 2.04%	250,136 $1.27 Million
Q3 2021 Nov 15, 2021	SELL	$13.62 - $19.48 $136,200 - $194,800	-10,000 Reduced 3.92%	245,136 $3.63 Million
Q2 2021 Aug 16, 2021	BUY	$16.94 - $19.89 $4.32 Million - $5.07 Million	255,136 New	255,136 $3.61 Million

12.7M

9.2K

118K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $206M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Newtyn Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Newtyn Management, LLC with notifications on news.